Pfizer’s Stock Buy Rating: Undervalued with Growth Potential and Strategic Management Actions
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
Is Pfizer a Buy Right Now or a Value Trap?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer (PFE) Gets a Hold from J.P. Morgan
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...
These Stocks Are Moving the Most Today
Dow, S&P 500, and Nasdaq futures are falling in premarket trading Monday as the stock market weighs up Middle East fears and looks ahead to CPI inflation data.
2 Beaten-Down Stocks to Buy and Hold for a Decade
The company also recently reported positive phase 2 results for ponsegromab, a potential medicine for cancer cachexia -- ...
Pfizer Inc. (PFE): Why Are Street Analysts Bullish On This Wide Moat Stock Now?
We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...
Seeking Alpha27d
Pfizer: The Rally May Just Be Getting Started
PFE trades at 11.2-times our 2025 EPS estimate, compared to an average of 23.0 for our coverage universe of large-cap biopharma stocks. Thus, if we assume that Pfizer will indeed beat the ...